The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health. Their study appears in Diabetes, Endocrinology, and Metabolism.

Previous studies have indicated that the system-wide inflammation that occurs in obesity plays a role in the development of type 2 diabetes. In the current study, researchers led by Jack A. Yanovski, M.D., Ph.D., of NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) randomly assigned 21 study participants to received colchicine twice a day for 3 months, while 19 participants received a placebo. Colchicine suppresses a multi-protein complex called NLRP3, which triggers the inflammation seen in obesity.

Related posts:

  1. Medicare Card, NIH researchers find potential target for reducing obesity-related inflammation Medicare Card, NIH researchers find potential target for reducing obesity-related inflammation...
  2. Medicare Card, NIH study finds interventions to prevent type 2 diabetes give good return on investment Medicare Card, NIH study finds interventions to prevent type 2 diabetes give good return on investment...
  3. Medicare Card, Healthy diet may reduce high blood pressure risk after gestational diabetes, NIH study suggests Medicare Card, Healthy diet may reduce high blood pressure risk after gestational diabetes, NIH study suggests...
  4. Findings in mice have potential to curb obesity and type 2 diabetes Scientists at the National Institutes of Health have uncovered a pathway in mice that allows white fat — a contributor to obesity and type 2 diabetes — to burn calories in a way that’s normally found in brown fat and muscle. The findings are in the July 6 edition of Cell Metabolism....
  5. Medicare Card, Endocannabinoids trigger inflammation that leads to diabetes Medicare Card, Endocannabinoids trigger inflammation that leads to diabetes...
  6. Medicare Card, Gene therapy shows promise for treating Niemann-Pick disease type C1 Medicare Card, Gene therapy shows promise for treating Niemann-Pick disease type C1...
  7. Medicare Card – Type 2 Diabetes Improvements in insulin release wane after treatment stops in adults with early type 2 diabetes A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly […]...
  8. New Compound Improves Obesity-Related Health Complications in NIH-Led Study An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online today in the Journal of Clinical Investigation....
  9. Medicare Card, Diabetes drug may prevent recurring strokes Medicare Card, Diabetes drug may prevent recurring strokes...
  10. Medicare Card, Islet transplantation restores blood sugar awareness and control in type 1 diabetes Medicare Card, Islet transplantation restores blood sugar awareness and control in type 1 diabetes...
  11. Medicare Card, NIH clinical trial begins for treatment of rare, fatal neurological disorder Medicare Card, NIH clinical trial begins for treatment of rare, fatal neurological disorder...
  12. Medicare, NIH researchers identify genetic elements influencing the risk of type 2 diabetes Medicare, NIH researchers identify genetic elements influencing the risk of type 2 diabetes: A team led by researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has captured the most comprehensive snapshot to date of DNA regions that regulate genes in human pancreatic islet cells, a subset of […]...
  13. Two drugs better than one to treat youth with type 2 diabetes A combination of two diabetes drugs, metformin and rosiglitazone, was more effective in treating youth with recent-onset type 2 diabetes than metformin alone, a study funded by the National Institutes of Health (NIH) has found. Adding an intensive lifestyle intervention to metformin provided no more benefit than metformin therapy alone....
  14. Medicare: Intensive therapy halves kidney disease in type 1 diabetes Controlling blood glucose early in the course of type 1 diabetes yields huge dividends, preserving kidney function for decades....
  15. Medicare Card, Weight loss does not lower heart disease risk from type 2 diabetes Medicare Card, Weight loss does not lower heart disease risk from type 2 diabetes...